In 1 H NMR metabolomic datasets, there are often over a thousand peaks per spectrum, many of which change position drastically between samples. Automatic alignment, annotation, and quantification of all the metabolites of interest in such datasets have not been feasible. In this work we propose a fully automated annotation and quantification procedure which requires annotation of metabolites only in a single spectrum. The reference database built from that single spectrum can be used for any number of 1 H NMR datasets with a similar matrix. The procedure is based on the generalized fuzzy Hough transform (GFHT) for alignment and on Principal-components analysis (PCA) for peak selection and quantification. We show that we can establish quantities of 21 metabolites in several 1 H NMR datasets and that the procedure is extendable to include any number of metabolites that can be identified in a single spectrum. The procedure speeds up the quantification of previously known metabolites and also returns a table containing the intensities and locations of all the peaks that were found and aligned but not assigned to a known metabolite. This enables both biopattern analysis of known metabolites and data mining for new potential biomarkers among the unknowns.
Introduction
Metabolomic analysis of biological samples using highresolution 1 H NMR spectroscopy is an active field of research [1] . 1 H NMR has the advantage of providing reproducible quantification results [2, 3] , but its main disadvantages are peak overlap and a relatively high limit of detection. Much of the data analysis effort in the field has been focused towards alignment [4] [5] [6] [7] or binning [8] [9] [10] [11] of spectra followed by chemometric analysis using methods such as principal-components analysis (PCA) [11] [12] [13] and partial least-squares discriminant analysis (PLS-DA) [14] . In recent years however, direct quantification of metabolites from spectral data has grown in popularity [15] . To make high-throughput quantification possible, development of automated methods is required.
Automated quantification of metabolites from 1D 1 H NMR data of complex biological samples is a challenging task. Peak misalignments and peak overlap in crowded regions of the spectra are problems not easily overcome [16] . Differences in the physical and chemical properties of samples of biological origin, for example urine samples, cause peaks to shift as much as up to 0.1 ppm between analyses even in samples buffered to a fixed pH and measured at controlled temperatures. 1 H NMR spectra often contain as many as a thousand peaks, causing much overlap and background signal in crowded regions. On the other hand, each analyte gives rise to several signals in 1 H NMR spectra, which makes it possible to select the peaks that carry the highest quality information, which we define here as the peaks that have the least overlap and highest signalto-noise ratio. This has traditionally been done by visually inspecting the amount of overlap in the spectral regions associated with a specific analyte and performing quantification using the peak(s) that appear to be the least affected by such problems [17] [18] [19] . For a fully automated method of quantification, however, peak selection must be performed by a computer algorithm rather than humans.
Recently, manual targeted spectral profiling assisted by software such as Chenomx NMRSuite has become popular [20, 21] ; this has enabled quantification of many metabolites in complex biological mixtures by use of 1 H NMR [22, 23] . Performing targeted spectral profiling is labor-intensive and often additional experiments must be performed to aid the assignment of peaks in crowded regions of the spectrum [22] .
In this paper we present a completely automated procedure encompassing methods for peak detection, alignment, peak selection, background correction, and quantification. The peak detection and alignment procedures have been described previously [5, 24] whereas the peak selection, background correction, and quantification methods have not. Using this procedure, we can go from raw spectra to tables of absolute concentrations with little or no user input. We report validation of the procedure by use of synthetic metabolite mixtures of known concentrations. We also validated the procedure by comparing quantification of metabolites in urine samples using our procedure with targeted spectral profiling using Chenomx NMRSuite 7.1 (Chenomx. Edmonton, Canada). To illustrate the usefulness of the procedure, we applied it to a toxicology study on rat urine and show that the metabolite concentrations determined by the procedure can be interpreted in terms of the lesions developed by the animals.
Experimental

Dataset A
Synthetic Arabidopsis mixture preparation
Twenty-four synthetic mixtures were prepared for this experiment. Each sample contained twenty-six metabolites present in Arabidopsis thaliana tissue extracts and three non-biological standards (HEPES, sorbitol, and DSS . Although each mixture had a unique metabolite profile, the samples were designed to group into six classes with biologically relevant concentrations and standard deviations. The concentrations are listed in Table S1 in the Electronic Supplementary Material. The synthetic mixture samples are further discussed in the original publication [25] .
NMR spectroscopy
NMR spectra were acquired on a Varian 600 MHz spectrometer (Varian, Palo Alto, CA, USA) equipped with a 5-mm triple resonance cold probe and a sample changer. The probe was tuned, matched, and shimmed by hand for the first sample. All subsequent samples were collected using an automated shimming and data-acquisition macro written in-house at the Department of Biochemistry, University of WisconsinMadison. One-dimensional 1 H NMR spectra of each sample were collected using 90°pulses (9.625 μs) with four acquisitions, four silent scans, and a pre-acquisition delay of 1 s and an acquisition time of 2 s. Spectral acquisition settings used were: 4 FIDs were collected into 32 k complex data points, 10,000 Hz spectral width, at 298 K. The data were autophased and baseline-corrected using in-house software.
Dataset B
Sample and batches
Dataset B consists of 20 1 H NMR spectra measured on rat urine. In the study, rats were dosed with tetracycline once per day according to Table 1 . Urine samples were collected for 17 h during day 3, 7 h after dosing. The samples were maintained on ice at approximately 4°C during collection and 1% (w/v) sodium azide was added to each tube to prevent bacterial contamination. The urine samples were stored at −80°C and were thawed at room temperature before analysis. Urine (400 μL) was mixed with 200 μL 0.2 mol L −1 phosphate buffer (pH 7.4) in 1.5-mL Eppendorf tubes and was centrifuged at 6350g and 4°C for 5 min. The supernatant (500 μL) was transferred to 5-mm NMR-tubes to which 50 μL TSP solution in D 2 O (1 mg TSP/mL D 2 O) was added. The tubes were ultrasonicated and placed in the NMR spectrometer. From each urine sample, 80 μL was pooled group-wise to obtain a total of 400 μL per group. These pooled samples were then treated according to the procedure described above. This results in 18 samples (five for each group plus one pooled sample per group); two samples were acquired in spectral duplicates yielding a total of 20 spectra. The animal study and the treatment of the study data were performed in accordance with national study regulations.
NMR data acquisition
NMR data were acquired using a Bruker DRX-600 spectrometer at 600.23 MHz for 1 H observation (Bruker BioSpin, Rheinstetten, Germany). A 5-mm BBI probe was used for the study. Spectra were acquired using a standard Bruker NOESY presaturation pulse program (relaxation delay-90°-τ 1 -90°-τ m -90°-acquire-FID), where τ m 0100 ms. The residual water resonances were suppressed by presaturation during the relaxation and mixing time (τ m ). Spectral acquisition settings used were: 512 FIDs were collected into 64 k complex data points, 12,019 Hz spectral width, 2.73 s acquisition time, 4.83 s total pulse recycle delay, at 300 K.
NMR spectral data processing
The spectra were corrected for phase and baseline distortions, and referenced internally to the TSP signal at 0 ppm using in-house automatic software (PhaseCore ver. 4.0, by Dr Ralf Torgrip) for Matlab. The spectra were normalized using the intensity of the TSP signal.
Dataset C
Samples and batches
The rat urine ethionine dataset has been described elsewhere [26] . Briefly, urine was sampled twice a day (0-7 h and 8-24 h) on day five and day two before, and days 1-7 after the onset of ethionine dosing. The samples were stored on ice during collection, and then 1% (w/v) sodium azide was added to 1 mL portions, which were centrifuged at 500 g for 10 min. The resulting supernatants were stored at −80°C. O) , was added at a final concentration of 0.09 mg mL −1 . The specifics for each group can be found in Table 2 . The animal study and treatment of the study data were performed in accordance with national study regulations. The study has been reported elsewhere [5, 24, 26] .
NMR data acquisition
NMR data were acquired using a Bruker DRX-600 spectrometer operating at 600.23 MHz for 1 H observation (Bruker Analytische Messtechnik, Rheinstetten, Germany). A 4-mm FISEI 1 H-13 C Z-GRD probe was used for the study. Spectra were acquired using a standard Bruker NOESY presaturation pulse program (relaxation delay-90°-τ 1 -90°-τ m -90°-acquire-FID), where τ m 0100 ms. The residual water resonances were suppressed by presaturation during the relaxation and mixing time (τ m ). Spectral acquisition settings used were: 64 FIDs were collected into 32 k complex data points, 12,019 Hz spectral width, 2.73 s acquisition time, 4.83 s total pulse recycle delay, at 300 K.
NMR spectral data processing
The acquired FIDs were zero filled to double the number of data points and multiplied by an exponential line broadening function of 0.3 Hz before Fourier transformation. The spectra were corrected for phase and baseline distortions, and referenced internally to the TSP signal at 0 ppm using inhouse automatic software (PhaseCore ver. 4.0, by Dr Ralf Torgrip) for Matlab. The spectra were normalized using the intensity of the TSP signal.
Data analysis
The general workflow of the procedure for automatic quantification of metabolites in metabolomic 1 H NMR datasets is presented in Fig. 1 . The steps involved in the analysis are:
& A reference database is needed. The database consists of a single spectrum measured on a sample similar to the sample to be quantified. The database also contains chemical shifts of several peaks and abundances for each metabolite that is assigned in the spectrum. Metabolites in the reference database can be assigned by using, for example, spectral profiling software such as Chenomx NMRSuite or 2D NMR experiments. & The spectra to be quantified are peak-detected. Each peak-detected spectrum is represented by a list of ppm values and a list of corresponding peak intensities. Peaks are detected by using a zero-area filter [28] -based approach described elsewhere [24] . & The peaks are aligned over the sample dimension by the generalized fuzzy Hough transform (GFHT) algorithm [24] . & Peaks that carry the highest quality information about each metabolite are selected. The selection is based on metabolite-wise principal-component analysis. & Each metabolite is quantified relative to the known concentration stored in the reference database by a method similar to principal-component regression (PCR) [27] .
The details of each step in the procedure are described below. The computation time for dataset B using this procedure was 2 min on a Hewlett Packard desktop computer equipped with a single-core 3.00 GHz Pentium processor and four gigabytes of RAM. The computation time scales linearly with the number of samples and linearly with the number of metabolite peaks included in the reference database.
Reference database
The presented procedure for automated annotation and quantification of metabolites in 1 H NMR metabolomic data requires a database containing peak positions in a single spectrum measured on a sample similar to those to be analyzed. The spectrum, together with the peak positions and abundances for each metabolite in the sample the spectrum was acquired from, are henceforth referred to as the reference database. The database can either be built from a spectrum in the dataset to be analyzed or a database from a previously analyzed dataset can be re-used. The quantification step of the procedure yields concentrations relative to those in the reference database. Therefore accurate Fig. 1 Schematic workflow of the procedure for automated annotation and quantification presented in this work quantification of metabolites in the database-building step is important if the desired result is absolute metabolite concentrations. If relative quantification of metabolites is sufficient for the purposes of the data analysis, the nominal concentration of each metabolite in the reference database can be set to 1. Because metabolite quantities and peak positions only have to be found manually in one spectrum even when creating a new database from nothing, the manual labor required in analyzing one dataset is independent of the number of samples. Building a reference database requires expertise in NMR spectroscopy but once it has been built, it can be applied to any similar 1 H NMR datasets. For datasets B and C, we created a reference database containing 21 metabolites, totaling 92 peaks assigned in one spectrum. The database was built with aid from Chenomx NMRSuite 7.1. The metabolites with assigned peak positions in the reference database is found in Table 5 . For validation and for demonstrating how a new reference database can be constructed without relying entirely on Chenomx, we also built a new database for dataset A from nothing using correlation analysis on GFHT-aligned peak tables. The reference database for dataset A can be found in Table 3 .
Peak detection
Before annotating the metabolites of the dataset from the reference database, the spectra have to be peak detected. In this work, a zero-area filter [28] -based method described in Ref. [24] is used. It uses the TSP peak shape as the basis for the zero-area filter instead of using a theoretical shape, for example described by a Lorentzian function. The method does not require any data except for a minimum signal-tonoise factor which was set to 3. For further details, refer to Ref. [24] .
GFHT alignment
The alignment method used in this work is based on that in earlier publications [24, 29] but has been improved in terms of reduced computation time and eliminated need for user input. Each peak in the reference database is aligned by maximizing the GFHT target function h in Eqs. (1) and (2) . Note that the target function has been slightly altered from its original form [30] to increase speed of computation and to avoid excessive values of h in crowded regions of the spectra. This version is equivalent to using the maximum of the fuzzy region in the GFHT instead of using the sum. The algorithm is now: & Create a model for peak positions (s) in the dataset (Eq. 1). This model will later be applied to every peak in the reference database in order to match them to peaks in the dataset to be analyzed. The components in this model are:
-s is a vector (samples×1) of modeled positions for a peak, it is a function of the independent variables α and the constants M and k. -M is a matrix (samples ×model peaks) of positions relative to the reference database (in data points) of several well defined and easily identifiable model peaks in the dataset. This matrix is created by finding positions of local maxima in small segments of the spectra where the sought peaks dominate the signal. Any peak that shifts and is easy to identify in all samples can be included in M. In this work, we used 7 peaks to construct M. -α is a vector (model peaks×1) of Hough parameters, one for each peak in M. They are the independent variables of the model. Automated annotation and quantification of metabolites in 1 -k is the position of the peak in the reference database (in data points).
& For each peak in the reference database, maximize the Hough score h in Eq. (2) by varying the parameter set α.
The optimization is performed using a slightly modified version (lower initial step size) of the built-in simplex optimization function in MATLAB (fminsearch). If the optimization does not converge to a value of h above a userdefined cut-off (h>0.6 was used in this work) the peak is discarded. The components of the equation for h are:
-s i is the modeled position of the peak in spectrum i. The model is described in Eq. (1). -z i is the actual position of the peak closest to s i in the peak-detected list for spectrum i. -N is the number of spectra in the dataset.
-σ is the user-defined GFHT fuzzy parameter, we used σ01 data point for all three datasets.
& After the optimization, the modeled positions in s i are adjusted slightly with up to 3 data points (user-defined parameter) to better match z i . The peak positions in s i are then passed on to the peak-selection algorithm.
A more complete version of the GFHT alignment algorithm can be found in the Electronic Supplementary Material. The modification of Eq. (2) from the original form can give the appearance that the method is significantly different from the original GFHT. This is not so; the equations are equivalent as long as only one peak is found within the fuzzy region of the GFHT. When there are several peaks, the new version only counts the score of the closest one and disregards the rest. This is an advantage because h does not get excessive values in crowded regions of the spectra. Fig. 3 Explained variance of leave-one-out cross-validation from PCA models of three analytes from dataset A as a function of number of peaks removed. The curves for aspargine and malate have distinct knee-points which indicate the cut-off between removing low-quality peaks and removing high-quality peaks. The curve for proline does not have a distinct knee-point, indicating that the peak quality is more evenly distributed among the peaks
Peaks used for quantification
Peaks not used for quantification Fig. 2 The PCA-based peakselection method applied to aspargine (10 aligned peaks) in dataset A. All peaks originate from one analyte and 1 PC should ideally describe 100% of the variability in the peak intensities. Peaks that do not cluster along PC 1 are removed before quantification
Peak selection
For each metabolite in the database, a subset of the peaks is selected for quantification. The reasoning behind this is that not all peaks carry high-quality information, because of peak overlap, misalignments, spectral noise, etc. Peak selection is performed by use of the following algorithm.
1.
The spectral intensities at the positions of all the aligned peaks for the metabolite are put into a (samples × peaks) matrix X. 2. X is centered and scaled to unit standard deviation. 3. PCA is performed; the peak with the highest absolute PC 2 loading value is removed from X. 4. The procedure is repeated until the explained variance of cross-validation (leave-one-out, projecting the leftout sample on the PCA loadings calculated from the remaining samples) reaches a pre-determined cut-off (set by user to 95-99% depending on the noisiness and complexity of the data).
If only two peaks remain and the explained variance still
has not reached the cut-off, the peak with the highest relative standard deviation is removed and the remaining peak is used for quantification.
The method is shown for aspargine (dataset A) in Figs. 2 and 3. Four peaks are found to be outliers because of overlap or misalignments and are automatically removed before quantification. A cut-off of 99% explained variance was used for dataset A, 95% was used for datasets B and C. This was decided because the background matrix is more complex in the urine samples and the metabolite concentrations are lower.
Quantification
The selected peaks for the metabolite are used in a singlepoint calibration model similar to PCR. Single-point calibration is used because it requires only one reference concentration-an advantage because determining reference concentrations is labor-intensive.
& PCA is performed on the intensities of the selected peaks for the metabolite, including the reference database. The PC 1 scores t 1 are used as the independent variable in the calibration model. 
& The metabolite concentrations c of all the samples in the dataset are calculated using the entire PC1 scores vector t 1 :
Results Construction of a reference database for dataset A Dataset A comprises 24 1 H NMR spectra of synthetic mixtures of metabolites created as a test dataset for error analysis of quantification methods [25] . They contain a mixture of 26 different small molecules including seven components with variable concentrations, ranging from 5.5 mmol L −1 to 29.1 mmol L −1 . The objective of the reference database construction step is to find several peaks that originate from each of these metabolites and assign them accurate chemical shifts and quantities in one spectrum in the dataset. The reference database is then used to calculate concentrations for the individual metabolites in the whole dataset using the procedure described in the data analysis section.
First, the dataset was peak-detected and aligned using the GFHT algorithm. The purpose of this step was to allow for correlations between peak intensities to be calculated over the entire dataset. The GFHT alignment resulted in 328 aligned peaks with correspondence over all the 24 samples. The first spectrum in the dataset was chosen for the reference database. For each of the seven metabolites, one peak was assigned manually in the reference database (assisted by 1 H-13 C HSQC data, published by Lewis et al. [25] ).
Correlations between the intensities of the assigned peak and all aligned peaks in the database were calculated. All peaks with R 2 values larger than 0.9 (Table 3 ) were compared to peaks in a pure metabolite spectrum (Chenomx NMRSuite 7.1) and included in the database for that metabolite if a close match was found. All peaks in the pure metabolite spectra could not be recovered in the aligned data. This is to be expected because some peaks in complicated multiplets are very small and others may be completely or partially overlapped by peaks from other metabolites.
Quantification of metabolites in dataset A
Dataset A (synthetic Arabidopsis plant extract samples) was processed through the proposed procedure. Table 4 and Fig. 4 show a comparison between our results and the true concentrations. Generally the results are in agreement, with an average R 2 value of 0.98 and average mean square relative error of prediction equal to 6.4%. Previously, an average error of 16.2% has been reported for the same data using manual integration of selected peaks and external standard calibration [25] . Complete results from the quantification can be found in Table S2 in the Electronic Supplementary Material.
Construction of a reference database for datasets B and C The reference database used for datasets B and C was built using Chenomx NMRSuite 7.1. The first spectrum in dataset Fig. 6 B was used to construct the database. For each metabolite, all library peak clusters found in Chenomx were compared manually with the spectrum chosen for the reference database. Peak clusters for which a close match was found in the spectrum were included in the peak list for that metabolite in the reference database. The metabolite concentration obtained from Chenomx was used as the reference concentration in the reference database. This procedure generated between 1 and 16 peaks per metabolite (Table 5) .
Quantification of metabolites in dataset B
The procedure was used to quantify the metabolites in the metabolite database (Table 5 ) in dataset B (tetracycline rat urine dataset) and compared with manual spectral profiling using Chenomx NMRSuite 7.1. The result of the comparison is found in Table 6 and Fig. 5 . For most of the metabolites the two methods were in agreement. The metabolites with the highest differences (maltose, betaine, allantoin) had their peaks in very crowded regions of the spectra, making manual spectral profiling difficult and somewhat arbitrary. Eight hundred unassigned peaks with correspondence over the entire dataset but without metabolite assignment were also generated by the GFHT-alignment algorithm; these peaks were not analyzed in this work. Three of the samples in dataset B are pool samples, these samples each consist of a mixture of five other samples. The relationship between the pool sample metabolite concentrations and the average metabolite concentration of the five samples comprising the pool is linear with slope close to unity from the highest measured concentrations around 7 mmol L −1 down to the lowest measured concentrations around 0.01 mmol L −1 (Fig. S1 in the Electronic Supplementary Material). This shows that the presented method can take advantage of a large portion of the dynamic range of the 1 H NMR technique. The quantification results from dataset B can be found in Table S3 in the Electronic Supplementary Material.
Quantification of metabolites in dataset C
For this dataset we investigated how well the results from the procedure can be used for following metabolic changes in response to different dosing regimes with ethionine. The procedure was applied to the 335 samples in dataset C (ethionine rat urine dataset). No validation against a second method was used for this dataset because it was deemed too time-consuming to perform manual spectral profiling of all 335 samples and the method has already been validated using datasets A and B. The quantification results can be found in Table S4 in the Electronic Supplementary Material. Several metabolites were found to correlate with the conditions of the rats in the various stages of the study. Figures 6 and 7 show the concentrations of 15 metabolites for each animal group at each time-point; concentrations of citrate, 2-oxoglutarate, and succinate decreased rapidly during day 1 in the dosed group except for the low-dose group (group 2). Group 2 has a slight decrease in succinate levels compared with group 1 from day 2 and onward (p00.003, change 0 0.8). Group 4 returned to normal concentrations of those metabolites around day 5 (day 4 for succinate). The concentrations of glucose and alanine increased drastically for group 4 during day 3, the levels started to decrease again during day 6 but never reached normal levels. A similar pattern can be seen for methyl succinate, but here the increase in concentrations can be seen already during day 2. Also, group 2 has an elevated level of methyl succinate in the day-urine (marked as pm in Figs. 6 and 7) from day 3 and onward (p06×10 −7 , change 0 1.45) though much less so than group 4. N,N-dimethylglycine concentrations increase drastically in group 4 on day 5 and then decrease but never return to normal levels. Trigonelline concentration spikes during day 3 for groups 3 and 4, and then returns to normal levels for group 4 (group 3 was euthanized at this point). For the other metabolites, no clear pattern can be seen. These patterns can also be seen in the metabolic trajectories in Figs. 8 and 9 . Especially when every concentration is scaled to unit standard deviation (Fig. 9) , it becomes clear which metabolite is associated with each stage of the study for the high and medium-dose groups. The low-dose group (group 2) cannot clearly be distinguished from the control groups (group 1 and 5) in these figures, indicating that the effect on their metabolism from the dosing is not very significant.
In addition to the peaks assigned to a particular metabolite, 743 unassigned peaks with correspondence over the entire dataset were aligned by the GFHT-algorithm; for an analysis of these peaks, refer to a previous publication on this dataset [5] . Autoscaled data PC1 PC2 G1 G2 G3 G4 G5 G6 G7 Fig. 9 The metabolic trajectories for the different groups in dataset C shown as a PCA bi-plot after meancentering and scaling to unit standard deviation. The intermediate stage of the study (day 1 pm to day 3) is characterized by a shift left and down for the high-dose groups and the late stage (day 4 and onwards) by a shift up and left for the remaining high-dose group
Conclusions
The procedure for automatic annotation and quantification of metabolites presented in this work is a significant improvement in high-throughput data analysis of 1 H NMR data of biological origin. Metabolite concentrations can be determined even in very difficult sample matrices, for example urine, for which other automated methods have failed [15] . The level of automation in each step is very high. Only a few values have to be set by the user for each dataset-two values for the alignment method and one for the peak selection.
The method has been validated both against true concentrations in synthetic mixtures and against manual targeted spectral profiling using Chenomx NMRSuite 7.1. This enables us to compare our results with results from studies using Chenomx and also indicates that the concentrations obtained are in agreement with the actual concentrations. The method has been shown to work in the range 0.01 to 7 mmol L −1 which is a typical dynamic range for target metabolites in urine samples.
